Log in to save to my catalogue

Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure—an impact...

Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure—an impact...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_744592498

Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure—an impact similar to male gender or smoking in schizophrenic patients

About this item

Full title

Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure—an impact similar to male gender or smoking in schizophrenic patients

Publisher

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Journal title

European journal of clinical pharmacology, 2010-05, Vol.66 (5), p.465-474

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

More information

Scope and Contents

Contents

Purpose The impact of the UGT1A4, CYP1A2, and MDR1 genetic variants on olanzapine plasma levels, in relation to those of other individual factors, such as gender, smoking status, body weight, and age, was investigated in patients with schizophrenia. Methods A total of 121 patients were recruited from psychosis-specialized outpatient departments in...

Alternative Titles

Full title

Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure—an impact similar to male gender or smoking in schizophrenic patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_744592498

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_744592498

Other Identifiers

ISSN

0031-6970

E-ISSN

1432-1041

DOI

10.1007/s00228-009-0783-8

How to access this item